We have had the ability to cure many people of hepatitis C (HCV) -- a common viral infection of the liver -- since 2011. These new drugs are effective at curing most strains of the virus and have far fewer side effects than earlier generations of treatment. Despite these major scientific advances, however, hepatitis C rates remain high, particularly among those who are also living with HIV, as well as among people in prison and people using drugs, Buy Hep C Drugs Online particularly drugs taken by injection. Our lack of progress toward eliminating hepatitis lies in a poor screening and surveillance system, the continuing opioid epidemic, and the high cost of the cures -- which has led many insurers, most notably Medicaid, to limit treatment to those who are already suffering some of the long-term consequences of this infection. Though all of these drugs have been hailed as major medical breakthroughs, much of the discussion around them has focused on their exorbitant price tags. When sofosbuvir (Sovaldi) was released, it made news because a 12-week round of treatment came in at a total of $84,000. Harvoni cost even more -- $94,500 for a 12-week course, though some patients may be cured after only eight weeks, or $63,000. Gilead's newer offering, Epclusa, goes for just over $74,000. The gamechanger in the market may be Mavyret, which costs $26,500 for treatment. As of January 2019, there are also authorized generic versions of some of these drugs available at lower prices. There have been many arguments about whether these prices may be justified if they actually do provide a permanent cure. Patients with hep C who are not cured often go on to need far more expensive care. One study estimated that yearly care for an HCV patient without liver damage is approximately $5,800. This goes up to over $27,000 each year for an HCV patient with decompensated cirrhosis of the liver, over $43,000 a year for an HCV patient with liver cancer, and over $93,000 a year for a patient who has had a liver transplant. While many programs, including state Medicaid programs, AIDS Drug Assistance Programs, and the Department of Veterans Affairs, have expanded coverage for HCV drugs in recent years, particularly as lower-cost medications hit the market, the high price tags are still a problem. Some state Medicaid administrators say they just can't afford to provide treatment to everyone who needs it. You can buy Indian Pharmacy Medixo Centre are Available Hep C Drugs Best Price Order Now: Hepcinat Lp // Myhep All // Velpanat // Ledifos // Dacihep // Daclahep // Hepcinat // Hepcinat Plus // Ledikast // Ledihep // Mydekla // Myhep // Myhep Dvir // Myhep Lvir // Natdac // Resof // Resof L // Resof Total // Sofovir // Sovihep // Sovihep V // Velakast // Velasof // Revolade // Revolade